E.A.P. Croydon
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Adverse Reactions
Papers in
-
- Drug-Induced Adverse Reactions 4
- Antibiotics Pharmacokinetics and Efficacy 3
- Pharmacological Effects of Natural Compounds 1
-
- Antimicrobial Resistance in Staphylococcus 5
- Co-authors
- R. Sutherland (2 shared papers)G. N. Rolinson (2 shared papers)Elisa Knudsen (1 shared paper)J. W. Harding (1 shared paper)Suresh Kumar Jain (1 shared paper)Jamie Murdoch (1 shared paper)Matthew F Pullen (1 shared paper)A. Geddes (1 shared paper)
- Journals
- Chemotherapy (2 papers)Drugs (2 papers)The Lancet (1 paper)Journal of Clinical Pathology (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
E.A.P. Croydon
11 papers receiving 327 citations
Peers
Comparison fields: 5 of 81
- Molecular Medicine 57
- Pharmacology 181
- Applied Microbiology and Biotechnology 14
- Clinical Biochemistry 33
- Infectious Diseases 67
Countries citing papers authored by E.A.P. Croydon
This map shows the geographic impact of E.A.P. Croydon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.A.P. Croydon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.A.P. Croydon more than expected).
Fields of papers citing papers by E.A.P. Croydon
This network shows the impact of papers produced by E.A.P. Croydon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.A.P. Croydon. The network helps show where E.A.P. Croydon may publish in the future.
Co-authors
The 13 scholars most cited alongside E.A.P. Croydon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1970 | 149 | |
| 2 | 1972 | 138 | |
| 3 | 1967 | 30 | |
| 4 | 1973 | 28 | |
| 5 | 1987 | 11 | |
| 6 | 1973 | 10 | |
| 7 | 1982 | 7 | |
| 8 | 1970 | 6 | |
| 9 | 1986 | 5 | |
| 10 | 1986 | 4 | |
| 11 | 2009 | 3 | |
| 12 | 2009 | 0 |
About E.A.P. Croydon
E.A.P. Croydon is a scholar working on Pharmacology, Infectious Diseases, Epidemiology, Dermatology and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 391 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (5 papers), Drug-Induced Adverse Reactions (4 papers), Pneumonia and Respiratory Infections (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Contact Dermatitis and Allergies (2 papers), Respiratory and Cough-Related Research (2 papers), Pharmacological Effects of Natural Compounds (1 paper) and Venous Thromboembolism Diagnosis and Management (1 paper). The work is most often cited by research in Molecular Medicine (57 citations), Pharmacology (181 citations), Applied Microbiology and Biotechnology (14 citations), Clinical Biochemistry (33 citations) and Infectious Diseases (67 citations). E.A.P. Croydon has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include R. Sutherland, G. N. Rolinson, Elisa Knudsen, J. W. Harding, Suresh Kumar Jain, Jamie Murdoch, Matthew F Pullen, A. Geddes, James M. Stevenson and Rebecca Sutherland. Their work appears in journals such as Chemotherapy, Drugs, The Lancet, Journal of Clinical Pathology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.